Abbonarsi

Endoscopic submucosal dissection for early cancers or precancerous lesions of the upper GI tract in cirrhotic patients with esophagogastric varices: 10-year experience from a large tertiary center in China - 17/05/23

Doi : 10.1016/j.gie.2023.01.023 
Shuai Zhang, MD 1, 2, , Ying-Di Liu, MD 1, , Ning-Li Chai, MD 1, Yi Yao, MD 1, Fei Gao, MM 1, Bo Liu, MM 3, Zhan-Di He, MM 1, Lu Bai, MM 1, Xin Huang, MB 2, Chao Gao, MB 2, En-Qiang Linghu, MD 1, , Lian-Yong Li, MD 2,
1 Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, Beijing, China 
2 Department of Gastroenterology and Hepatology, PLA Strategic Support Force Characteristic Medical Center, Beijing, China 
3 Department of Gastroenterology and Hepatology, The Second Medical Center of Chinese PLA General Hospital, Beijing, China 

Reprint requests: En-Qiang Linghu, MD, Department of Gastroenterology and Hepatology, The First Medical Center of Chinese PLA General Hospital, No. 28 Fuxing Road, Beijing 100853, China. Department of Gastroenterology and Hepatology The First Medical Center of Chinese PLA General Hospital No. 28 Fuxing Road Beijing 100853 China ∗∗ Lian-Yong Li, MD, Department of Gastroenterology and Hepatology, PLA Strategic Support Force Characteristic Medical Center, No.9 Anxiang North Road, Beijing, 100101, China. Department of Gastroenterology and Hepatology PLA Strategic Support Force Characteristic Medical Center No.9 Anxiang North Road Beijing 100101 China

Abstract

Background and Aims

Treatment strategies for early cancers or precancerous lesions of the upper GI tract in patients with cirrhosis and esophagogastric varices (EGVs) are complicated and risky. The aim of this study was to assess the efficacy and safety of endoscopic submucosal dissection (ESD) in the treatment of such patients and explore optimal treatment strategies.

Methods

We retrospectively enrolled 15 patients with cirrhosis and EGV who underwent ESD for early cancers or precancerous lesions of the upper GI tract from January 2012 to December 2021 at our center. Clinical features, endoscopic findings, treatment methods, adverse events, and follow-up data were analyzed.

Results

Of the 15 patients, 1 had a platelet count < 30 × 1000/mm 3 . Five were untreated for EGV, 1 was treated after ESD, 6 were treated before ESD, 1 was treated before and during ESD, and 2 were treated during ESD. The R0 resection rate was 100%. Of the 16 mucosal lesions, 15 were endoscopic resection bleeding (ERB)-0 or ERB-c1, and 1 was ERB-c2. No patient experienced deterioration in liver function. The only adverse events were fever in 2 patients and postoperative bleeding in 2 patients. During a median follow-up of 27 months, 1 patient’s esophageal high-grade dysplasia recurred at 19 months. No death resulted from the ESD procedure, liver function injury, or GI tumor itself.

Conclusions

ESD is an effective and safe treatment for early cancers or precancerous lesions of the upper GI tract in patients with cirrhosis and EGV. The incidence of severe adverse events is very low due to the development of individualized clinical treatment strategies.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : APC, EGV, EIS, ERB, ESD, EV, EVL, GV, HGD, ME + NBI, PB


Mappa


  DISCLOSURE: All authors disclosed no financial relationships.
 DIVERSITY, EQUITY, AND INCLUSION: We worked to ensure the following: gender balance in the recruitment of human subjects, ethnic or other types of diversity in the recruitment of human subjects, and that the language of the study questionnaires reflected inclusion. While citing references scientifically relevant for this work, we actively worked to promote gender balance in our reference list. The author list of this paper includes contributors from the location where the research was conducted who participated in the data collection, design, analysis, and/or interpretation of the work.


© 2023  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 97 - N° 6

P. 1031-1044 - giugno 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Long-term outcomes of local resection versus surgical resection for high-risk T1 colorectal cancer: a systematic review and meta-analysis
  • Yuxiang Chen, Weina Jing, Mo Chen, Zhu Wang, Junchao Wu, Jinlin Yang, Li Yang, Kai Deng
| Articolo seguente Articolo seguente
  • Safety and feasibility of same-day discharge after endoscopic submucosal dissection: a Western multicenter prospective cohort study
  • William King, Peter Draganov, V.Subhash Gorrepati, Maham Hayat, Hiroyuki Aihara, Michael Karasik, Saowanee Ngamruengphong, Abdul Aziz Aadam, Mohamed O. Othman, Neil Sharma, Ian S. Grimm, Alaa Rostom, B. Joseph Elmunzer, Dennis Yang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.